Establishment of a PPP2CA homozygous knockout human embryonic stem cell line via CRISPR/Cas9 system

被引:0
|
作者
Ding, Tongbin [1 ]
Gao, Zhe [1 ]
Liu, Hang [1 ]
Li, Yuan [1 ]
Liu, Shichao [1 ]
Jian, Liguo [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 2, Dept Cardiol, Zhengzhou 450014, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 2, Dept Cardiol, 2 Jingba Rd, Zhengzhou 450014, Henan, Peoples R China
关键词
D O I
10.1016/j.scr.2023.103029
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Protein phosphatase 2A (PPP2CA) is one of the four main Ser/Thr phosphatase enzymes, which involved in the negative control of cell growth and division. PPP2CA is the main protein phosphatase in the heart, which regulates Ca (2+) through a series of ion channels and transporters. In this study, we generated a PPP2CA homozygous knockout human embryonic stem cell line WAe009-A-25 based on the transient expression CRISPR/Cas9 system to investigate functional effect of PP1 deficiency. This cell line has multidirectional differentiation potential, normal karyotypic and trilineage differentiation potential in vivo.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Generation of a homozygous COX6A2 knockout human embryonic stem cell line (WAe009-A-47) via an epiCRISPR/Cas9 system
    Hang, Chengwen
    Song, Yuanxiu
    Wu, Fujian
    Dong, Tao
    Jiang, Mengqi
    Saleem, Amina
    Zhang, Siyao
    Chang, Yun
    Lu, Wenjing
    Cui, Ming
    STEM CELL RESEARCH, 2021, 50
  • [42] Generation of a RGS18 gene knockout cell line from a human embryonic stem cell line by CRISPR/Cas9
    Feng, Yashu
    Li, Xudong
    Zhang, Ling
    Sun, Yanling
    He, Yi
    Wen, Ruijuan
    Hu, Yaofang
    Wang, Xiaozhen
    Liu, Jiajun
    Long, Bing
    STEM CELL RESEARCH, 2020, 49
  • [43] Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9
    Yuan, Fang
    Guo, Dongsheng
    Gaob, Ge
    Liu, Yanli
    Xu, Yingying
    Wu, Yuhang
    Yang, Fan
    Ke, Xinrong
    Lai, Keyu
    Hong, Liangqing
    Li, Yin-xiong
    STEM CELL RESEARCH, 2017, 24 : 89 - 93
  • [44] Generation of a homozygous S100A1 knockout human embryonic stem cell line (WAe009-A-73) by the CRISPR/Cas9 editing system
    Zhang, Shuai
    Guo, Tianwei
    Song, Yuanxiu
    Jiang, Mengqi
    Jiang, Youxu
    Dong, Tao
    Zhang, Siyao
    Wang, Hong
    Hou, Xiaotong
    STEM CELL RESEARCH, 2022, 59
  • [45] Generating dHAND homozygous knockout human embryonic stem cell line (WAe009-A-59) by episomal vector-based CRISPR/Cas9 system
    Wang, Wei
    Bai, Rui
    Song, Xiantao
    STEM CELL RESEARCH, 2021, 55
  • [46] Generation of two RNF2 homozygous knockout human embryonic stem cell lines by CRISPR/Cas9 system (vol 47, 101885, 2020)
    Shan, Yongli
    Liang, Zechuan
    Ma, Lishi
    Zhang, Cong
    Zhang, Yanqi
    Zhang, Jingyuan
    Xiao, Lu
    Wei, Yanxing
    Yu, Yanhong
    STEM CELL RESEARCH, 2021, 57
  • [47] Generation of a KDM5D knockout human embryonic stem cell line with CRISPR/Cas9 technology
    Li, Ouhui
    Zhen, Yuting
    Sun, Chao
    Ma, Yanlin
    Li, Qi
    Wen, Luan
    STEM CELL RESEARCH, 2025, 83
  • [48] Generation of a MSX1 knockout human embryonic stem cell line using CRISPR/Cas9 technology
    Chiu, Weicheng
    Li, Anqi
    Wang, Tao
    Li, Weiqiang
    Zhang, Xinchun
    STEM CELL RESEARCH, 2022, 60
  • [49] Generation of GPAM knockout human embryonic stem cell line SYSUe-008-A using CRISPR/Cas9
    Sun, Chuanbo
    Li, Bing
    Yang, Miaomiao
    Guo, Ruirui
    Yuan, Simin
    Wang, Jichang
    Hu, Hao
    STEM CELL RESEARCH, 2021, 53
  • [50] Generation of CD16A gene knockout human embryonic stem cell line using CRISPR/Cas9
    Wu, Shunjie
    Deng, Haimei
    Lu, Bo
    Yuan, Lihua
    Wang, Xiaobo
    STEM CELL RESEARCH, 2022, 64